Cannabis Law Report

APRIL 16, 2019

Tracebility was and is the tracking of Cannabis and Cannabis-infused items and products from “see d to sale”, as directed to Washington and Colorado per the Cole Memo issued in August 2013. For example, the State required barcodes on all packages and this barcode was obviously assigned to groups or “lots” of inventory.

Seed-To-Sale 45

Seed-To-Sale Retail Packaging Pharmaceutical 45

Cannabis Law Report

SEPTEMBER 8, 2021

Flora will use TruTrace’s blockchain-enabled platform for seed-to-sale tracking of its cannabis products – including integration of Applied DNA’s molecular tagging technology – to offer Flora’s customers a complete product validation and authentication solution. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp.

Supply Chain 95

Supply Chain Pharmaceutical Seed-To-Sale Events 95

Cannabis Law Report

DECEMBER 22, 2019

The lack of sustainability, vast amounts of water and electricity necessary for cultivation is the elephant in the room of any smoke session. The lack of sustainability, vast amounts of water and electricity necessary for cultivation is the elephant in the room of any smoke session. AUTHOR: Heather Allman.

Packaging 96

Packaging Seed-To-Sale Agriculture Environment 96

Cannabis Law Report

JULY 26, 2021

The passage of this legislation greatly immediately accelerates our strategic vision of bringing our cannabis products to international markets as noted by our first international supply agreement out of Cosechemos while we focus expanding our global distribution platform of traditional consumer packaged goods. ” Columbia Decree.

Supply Chain 111

Supply Chain Seed-To-Sale Food Packaging 111

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma will seek to identify scientific gaps in the cannabis industry and ultimately work to translate that to pharmaceutical cannabis products backed by data. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. Annabelle Manalo-Morgan, Flora’s Lead Scientific Advisor.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

Cannabis Law Report

AUGUST 19, 2019

In order to legally produce, possess, supply, cultivate, import or export cannabis products, there are various regulatory requirements that must be met, depending on whether the product contains a controlled drug or is classified as a CBPM. 19 August 2019. Authors – Carolyn E. Pepper and Jess Parry. What substances are at issue?

Environment 45

Environment Food Seed-To-Sale Medicine 45

Project CBD

AUGUST 23, 2023

Earlier this year, the Food & Drug Administration disclosed that it would not regulate non-pharmaceutical CBD products, thereby putting the onus on Congress to devise an appropriate regulatory framework for cannabidiol and other hemp-derived cannabinoids. Whether growing or not” is being misconstrued to mean that the 0.3

Cannabinoids 141

Cannabinoids Hemp THC Safety 141